Is Ga-68 dotatate legal in the US?
Yes, FDA approved for scanning for neuroendocrine tumors.
BSome human evidenceFDA approvedas of 2026-10-26
Approved. Gallium Ga-68 dotatate was approved by the FDA on June 1, 2016 as NETSPOT (Advanced Accelerator Applications, now Novartis), a kit for preparing a PET imaging agent to localize somatostatin receptor-positive neuroendocrine tumors in adults and children. It is a single intravenous injection given before a PET scan, not a treatment. 2
Yes. NETSPOT was approved in June 2016 for PET imaging of somatostatin receptor-positive neuroendocrine tumors in adult and pediatric patients. 2
Read the full Ga-68 dotatate page
More on Ga-68 dotatate
Citations
- Deppen 2016, Journal of Nuclear Medicine: 68Ga-DOTATATE compared with 111In-DTPA-octreotide and conventional imaging for pulmonary and gastroenteropancreatic neuroendocrine tumors doi.org
- Novartis: NETSPOT (kit for preparation of gallium Ga-68 dotatate injection) prescribing information novartis.com
Reference information only, not medical advice. Drawn from the Ga-68 dotatate article, fact-checked against the cited sources. No dosing anywhere on this site.